Elderberry Demand Loud But Matherson Organics Silent In NAD Review Of Immune Benefit Claim
Executive Summary
The National Advertising Division says it will refer Matherson Organics to regulators for possible enforcement after it failed to provide a substantive response to an inquiry on an Instagram claim that suggested Vitamin Bounty Elderberry Immune Support could help prevent or treat COVID-19.
You may also be interested in...
US HBW Business News: OTC Migraine Treatment Device Cleared, Nestle Closes Aimmune Deal, More
Cefaly touts first OTC dual-Purpose eTNS migraine device available in US; Nestle Health Science closes on its acquisition of Aimmune Therapeutics; Elderberry supplement marketer Matherson Organics complies with NAD recommendations rather than face FTC scrutiny; and nutrition product firm Vidafuel closes on $1.6m financing round.
Like Consumer Health Ad Claims About COVID-19, Customer Testimonials Are False And Misleading
Nomolotus discontinued social media claims that its herbal supplement supports users’ immune systems during the COVID-19 pandemic and customers reviews referencing the virus after the National Advertising Division questioned the statements as misleading.
No Enforcement Immunity For Testimonials On Immunity Or Claims With 'Alert: No COVID-19 Cure'
Elderberry syrup marketer Provezza Health targeted review of claims consumers may link to COVID-19 prevention or treatment due to testimonials not dispelled by the firm. FDA and FTC warn CBD firm to discontinue claims noting immunity-boosting is the “best defense” against COVID-19.